We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-6.55%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$616M
AUM Growth
-$47.1M
Cap. Flow
+$2.74M
Cap. Flow %
0.45%
Top 10 Hldgs %
61.13%
Holding
110
New
18
Increased
5
Reduced
1
Closed
13
Avg Time Held
0.9 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$35.6M
2
HLTH icon
Cue Health Inc. Common Stock
HLTH
+$15.8M
3
CORS
Corsair Partnering Corporation
CORS
+$12.2M
4
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
+$7.96M
5
SONO icon
Sonos
SONO
+$5.45M

Top Sells

Rank Stock Value
1
FLNA icon
Filana Therapeutics
FLNA
+$32M
2
GRA
W.R. Grace & Co.
GRA
+$13.9M
3
SHLX
Shell Midstream Partners, L.P.
SHLX
+$13.5M
4
OPTU icon
Optimum Communications Inc
OPTU
+$10.2M
5
FATE icon
Fate Therapeutics
FATE
+$8.68M

Sector Composition

Rank Sector Weight
1 Healthcare 27.29%
2 Financials 14.03%
3 Industrials 13.51%
4 Miscellaneous 13.22%
5 Consumer Discretionary 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
FLNA icon
101
Filana Therapeutics
FLNA
$36.8M
– –
-375,000
Closed -$32M –
NS icon
102
DELISTED
NuStar Energy L.P.
NS
– –
-435,500
Closed -$7.86M –
CZOO icon
103
DELISTED
Cazoo Group Ltd
CZOO
– –
-5
Closed -$100K –
BRIVU
104
DELISTED
B. Riley Principal 250 Merger Corp. Units
BRIVU
– –
-225,000
Closed -$2.24M –
SHLX
105
DELISTED
Shell Midstream Partners, L.P.
SHLX
– –
-913,347
Closed -$13.5M –
AJAX.WS
106
DELISTED
Capri Listco Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exer
AJAX.WS
– –
-2,500
Closed -$5K –
FGNA.U
107
DELISTED
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
– –
-250,000
Closed -$550K –
CNST
108
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-182,500
Closed -$6.17M –
IHC
109
DELISTED
Independence Holding Company
IHC
– –
-54,711
Closed -$2.53M –
GRA
110
DELISTED
W.R. Grace & Co.
GRA
– –
-200,934
Closed -$13.9M –
1 2 3 4
5

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q3 2021 Portfolio in Review

As of Q3 2021, Bleichroeder LP held 110 positions worth $616M, down 7.1% from $663M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Bleichroeder LP's Q3 2021 filing shows 18 new, 5 increased, 1 reduced and 13 closed positions. Its largest new stake was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M. The largest sale was Filana Therapeutics, an estimated $32M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

  • Bleichroeder LP's largest Q3 2021 buy was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M.
  • Bleichroeder LP added most to Royalty Pharma in Q3 2021, an estimated $35.6M increase.
  • Bleichroeder LP's biggest Q3 2021 reduction was Optimum Communications Inc, cutting an estimated $10.2M.
  • Bleichroeder LP fully exited Filana Therapeutics in Q3 2021, selling an estimated $32M.
  • Bleichroeder LP's ten largest holdings make up 61% of its $616M portfolio in Q3 2021.
  • Bleichroeder LP opened 18 new positions and closed 13 in Q3 2021.
  • Bleichroeder LP's portfolio value fell 7.1% quarter-over-quarter to $616M.

Based on Bleichroeder LP's 13F filing for Q3 2021, filed 15 Nov 2021.